Comparing Desogestrel / Ethinyl Estradiol vs Ethinyl Estradiol / Norgestimate
| Desogestrel / ethinyl estradiol | Ethinyl estradiol / norgestimate |
|
|---|
| Desogestrel / ethinyl estradiol | Ethinyl estradiol / norgestimate |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Endometriosis, Birth Control, Abnormal Uterine Bleeding, Polycystic Ovary Syndrome, Gonadotropin Inhibition. Desogestrel / ethinyl estradiol may also be used for purposes not listed in... View more |
Prescription only
Prescribed for Acne, Endometriosis, Ovarian Cysts, Abnormal Uterine Bleeding, Birth Control, Gonadotropin Inhibition. Ethinyl estradiol / norgestimate may also be used for purposes not listed in this... View more |
Related suggestions Birth Control
Abnormal Uterine Bleeding
Endometriosis
Gonadotropin Inhibition
|
|||||||||||||||
| More about Desogestrel / ethinyl estradiol | More about Ethinyl estradiol / norgestimate | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Desogestrel / ethinyl estradiol has an average rating of 5.3 out of 10 from a total of 1572 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 38% reported a negative effect. |
Ethinyl estradiol / norgestimate has an average rating of 5.2 out of 10 from a total of 5746 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 42% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
|
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
|
|
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Apri, Azurette, Bekyree, Caziant, Cyclessa, Cyred, Cyred EQ, Desogen, Emoquette, Enskyce, Isibloom, Juleber, Kalliga, Kariva, Kimidess, Pimtrea, Reclipsen, Simliya, Velivet, Viorele, Volnea View more | Estarylla, Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Sprintec, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
20 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 493 drugs are known to interact with Desogestrel / ethinyl estradiol:
|
A total of 493 drugs are known to interact with Ethinyl estradiol / norgestimate:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
March 09, 2011 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.